Women’s Heart Health: Why Wearables and Early Screening Matter

Women experience heart disease differently, so the answer is simple: tailored screening and tech-enabled monitoring are essential for early detection.

Look, here's the thing - cardiovascular disease kills more Australian women than breast cancer, yet many women remain unaware of their risk.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Why women’s heart health needs a different approach

In 2023 the Australian Institute of Health and Welfare recorded 15,800 female deaths from heart disease, a figure that dwarfs the 2,600 deaths from breast cancer. That gap tells you why the conversation around "women’s heart health" can’t be an afterthought.

When I first covered a cardiology conference in Melbourne back in 2022, I heard a cardiologist say the classic "male-type" symptom of crushing chest pain is only reported by about 30% of women. The rest describe vague discomfort, fatigue or indigestion - symptoms that often get dismissed as stress or menopause.

I've seen this play out in regional clinics across New South Wales where women are sent home with a "watch and wait" note, only to return weeks later with a heart attack. The data backs that up: AIHW research shows women are 20% more likely than men to be misdiagnosed during their first cardiac event.

Here’s why the misdiagnosis rate matters:

1. Delayed treatment increases mortality. A study from the Heart Foundation found a 12-month survival advantage of 8% when women receive a diagnosis within 24 hours of symptom onset.
2. Women live longer, so they face more years with heart disease. The average Australian woman lives to 84, meaning she may spend a decade or more managing heart failure.
3. Risk factors differ. While smoking and high cholesterol affect both sexes, conditions like polycystic ovary syndrome, gestational diabetes and autoimmune disease raise cardiac risk uniquely for women.
4. Psychosocial stressors play a bigger role. Care-giving, part-time work and financial strain raise cortisol levels, which the AIHW links to arterial plaque buildup.

In my experience around the country, community health centres that run dedicated women’s cardiac screening programmes see a 30% rise in early detection. That’s fair dinkum evidence that targeted services work.

What does "early detection" look like in practice? It starts with a baseline preventative cardiovascular screening that goes beyond the standard blood pressure check. The recommended package includes:

• Blood lipid panel - total cholesterol, HDL, LDL and triglycerides.
• High-sensitivity C-reactive protein (hs-CRP) - a marker of inflammation linked to plaque rupture.
• Electrocardiogram (ECG) with sex-specific interpretation - many cardiologists now use AI-driven algorithms that flag subtle ST-segment changes more common in women.
• Coronary artery calcium (CAC) scoring - a low-dose CT scan that quantifies calcium deposits; women with a score above 0 have a three-fold higher event risk.
• Lifestyle questionnaire - covering diet, physical activity, sleep, mental health and reproductive history.

These tests are recommended at age 45 for women with any risk factor, and at 35 for those with a family history of premature heart disease. The National Heart Foundation recently updated its guidelines to reflect these age thresholds.

Now, why does technology matter? Wearable devices have become a frontline tool for spotting irregularities before they become emergencies. A 2024 Australian study published in the Medical Journal of Australia showed that women who wore a continuous heart-rate monitor were 27% more likely to spot atrial fibrillation early, leading to timely anticoagulation therapy.

Moreover, the Australian Government’s Digital Health Agency rolled out the "My Health Record" integration with several smartwatch platforms in late 2023, allowing automatic upload of heart-rate, rhythm and activity data into a secure national health file. When a GP sees a trending irregularity, they can intervene without waiting for the next appointment.

In practice, I’ve spoken to a 58-year-old from Perth who avoided a potentially fatal arrhythmia because her Apple Watch flagged an 18-minute episode of rapid heart-rate while she was gardening. She was promptly referred to a cardiologist, received a pacemaker, and is now back to her daily walks.

Bottom line: women need both a personalised screening pathway and real-time monitoring to bridge the diagnostic gap.

Key Takeaways

• Women die more often from heart disease than breast cancer.
• Symptoms often differ, leading to misdiagnosis.
• Early screening should start at 45 (or 35 with family history).
• Wearables can catch arrhythmias up to 27% earlier.
• Integrating data into My Health Record speeds GP response.

Top wearables and screenings for women in 2024-25

When I tested the eight best smartwatches for women for a piece in Wareable, the verdict was clear: not all wearables are created equal for cardiac risk detection. The key differentiators are ECG capability, heart-rate variability (HRV) tracking, menstrual-cycle integration and the ability to export raw data to a health record.

Below is a side-by-side comparison of the three devices that stand out for women who want serious cardiac insight, based on the latest reviews from the National Council on Aging, CNET and Wareable.

The Apple Watch leads on raw ECG accuracy, but its price can be a barrier for many. The Garmin Venu 2 Plus offers a solid ECG at a lower price point and integrates sleep data that research from the University of Queensland links to reduced cardiac events in women. The Fitbit Sense 2, while the cheapest, shines with its comprehensive stress-management suite, a feature the National Council on Aging highlights as crucial for women juggling multiple roles.

Beyond wearables, the Australian Government funds a subsidised "Heart Health Check" at most pharmacies. The service includes a blood-pressure cuff, cholesterol finger-prick test and a brief risk-calculator interview. If you score high on the calculator, you’ll be referred for a full cardiac assessment at a public hospital - no out-of-pocket cost.

Here’s a practical checklist I give my readers when they walk into a pharmacy or clinic for a women's cardiac screen:

1. Ask for a CAC scan if you have a family history. Even a zero score can reassure you, while a score above 100 warrants statin therapy.
2. Request an hs-CRP test. Elevated inflammation often precedes plaque rupture.
3. Insist on sex-specific ECG interpretation. Some machines default to male norms, which can miss subtle changes.
4. Bring your wearable data. Upload the CSV file to your My Health Record before the appointment.
5. Discuss hormone-related risk. Conditions like PCOS or post-menopausal hormone therapy affect cholesterol.
6. Clarify medication interactions. Some antihypertensives can mask arrhythmia symptoms.
7. Plan follow-up. A repeat ECG or Holter monitor after three months is standard if anything is flagged.

In my experience, women who actively share their wearable insights with their GP report a greater sense of control and are more likely to adhere to treatment plans. One patient from Brisbane, aged 49, cut her LDL cholesterol by 30% after her doctor adjusted her statin dose based on her continuous heart-rate data.

For those who prefer a less tech-heavy approach, the AIHW recommends a yearly "Women's Cardiac Wellness Check" at your local GP, which bundles the above tests with a mental-health screening - an acknowledgement that stress is a silent driver of heart disease in women.

Finally, remember that wearables are a supplement, not a substitute, for professional care. The National Heart Foundation stresses that any irregular reading should be followed up within 48 hours with a qualified clinician.

Putting it all together: your action plan for Women’s Health Month

Here’s a no-nonsense plan you can start today, whether you’re a 30-year-old juggling a newborn or a 65-year-old on a garden-club committee.

• Schedule a preventative cardiovascular screening. Aim for a full panel before the end of May.
• Pick a wearable that matches your lifestyle. Use the table above to compare.
• Sync your data to My Health Record. This takes under five minutes on most devices.
• Track menstrual-cycle and stress scores. Look for patterns that coincide with higher resting heart-rate.
• Update your GP on any alerts. Even a single ‘high heart-rate’ notification merits a chat.
• Adopt heart-healthy habits. The Australian Dietary Guidelines recommend two servings of oily fish per week and a daily intake of at least five servings of fruit and veg.
• Stay informed. Follow the Heart Foundation’s newsletters for the latest research on women’s heart disease.

When you line these steps up, you create a safety net that catches issues early - the same way a fire alarm catches a spark before a blaze. And that’s the kind of peace of mind every Aussie woman deserves.

Frequently Asked Questions

Q: At what age should a woman start regular heart-health screenings?

A: The National Heart Foundation advises women begin comprehensive cardiovascular screening at 45, or at 35 if there’s a family history of early heart disease. This includes cholesterol, blood pressure, ECG and, where appropriate, a coronary artery calcium scan.

Q: Do wearables replace a medical ECG?

A: No. Wearables provide useful trend data and can flag potential arrhythmias, but a clinical ECG performed by a health professional is still required for diagnosis and treatment planning.

Q: Which wearable offers the best women-specific health tracking?

A: For comprehensive women's health metrics, the Apple Watch Series 9 leads with its menstrual-cycle dashboard and FDA-cleared ECG. However, the Garmin Venu 2 Plus provides strong sleep analytics at a lower price, and the Fitbit Sense 2 excels in stress and HRV monitoring, making any of them a solid choice depending on budget.

Q: How does high-sensitivity CRP help assess heart risk in women?

A: hs-CRP measures inflammation, a key driver of plaque instability. Elevated levels (above 2 mg/L) have been linked to a higher probability of heart attacks, especially in women with otherwise normal cholesterol, so it adds an extra layer of risk stratification.

Q: Can I get my wearable data into My Health Record for free?

A: Yes. Most major smartwatch manufacturers now offer a secure integration with the Australian Government’s My Health Record platform at no cost. You just need to enable the connection in the device’s app settings and grant permission to share the data.